HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

minozac

a proinflammatory cytokine suppressing agent; structure in first source

Also Known As:

Mzc compound

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - minozac: 3
  - Pyridazines: 11
    - minozac: 3

Experts

1.	Wainwright, Mark S: 3 articles (07/2010 - 09/2007)
2.	Watterson, D Martin: 3 articles (07/2010 - 09/2007)
3.	Somera-Molina, Kathleen C: 2 articles (07/2009 - 09/2007)
4.	Van Eldik, Linda J: 2 articles (07/2009 - 09/2007)
5.	Chrzaszcz, MaryAnn: 1 article (07/2010)
6.	Dragisic, Tina: 1 article (07/2010)
7.	Venkatesan, Charu: 1 article (07/2010)
8.	Nair, Sangeetha: 1 article (07/2009)
9.	Anderson, Christopher: 1 article (09/2007)
10.	Behanna, Heather A: 1 article (09/2007)

Related Diseases

1.	Seizures (Absence Seizure) 07/01/2010 - "Minozac treatment prevents increased seizure susceptibility in a mouse "two-hit" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizures." 07/28/2009 - "Treatment after early-life seizures with Minozac, a small molecule experimental therapeutic that targets upregulated proinflammatory cytokine production, attenuated the enhanced microglial and cytokine responses, the increased susceptibility to seizures, and the greater neuronal injury in the 'two-hit' group. " 09/01/2007 - "Treatment with Minozac, a small molecule inhibitor of proinflammatory cytokine upregulation, following early-life seizures prevented both the long-term increase in activated glia and the associated behavioral impairment. "
2.	Traumatic Brain Injuries (Traumatic Brain Injury) 07/01/2010 - "Minozac treatment prevents increased seizure susceptibility in a mouse "two-hit" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizures."

Related Drugs and Biologics

1.	Cytokines